S&P 5007,631.47▼0.7% Nasdaq26,099.77▼1.0% Dow52,766.88▼0.8% Russell 2K2,920.13▼1.2% 10-Yr4.80%+4bp VIX16.34+1.42 WTI$90.79▲5.9% Gold$4,376.80▼1.2% EUR/USD1.160▼0.2% BTC$76,527▼1.1% Nikkei66,312▲0.3%
At close · Wed, Sep 2, 2026
Daily Market Updates.

Global Markets

HomeGlobal MarketsTrade & TariffsIndia Glycols demerger splits into three listed entiti…

India Glycols demerger splits into three listed entities

The split came after NCLT approval on 17 July 2026, and India Glycols shares briefly dropped to an intraday low of ₹229 on BSE as post-demerger pricing took effect.

India Glycols has completed its demerger into three separate entities, a move designed to reduce complexity and give each unit a clearer management focus, according to LiveMint Markets. The original company received NCLT approval for the scheme of arrangement on 17 July 2026 before completing the split on Tuesday, 1 September 2026.

Following the demerger, India Glycols shares saw an over 79% intraday fall on Wednesday, 2 September, as investors adjusted to the post-demerger pricing. The stock traded down to an intraday low of ₹229 on the BSE, and finished Tuesday, 1 September, 3.07% lower at ₹1,112.90.

The demerged units are India Glycols Limited, IGL Spirits Limited, and Ennature Bio Pharma Limited. LiveMint Markets said India Glycols Limited will hold the chemicals, glycols, bio-glycols, new speciality products, and industrial gases businesses, while IGL Spirits will control the spirits segment, including IMFL, country liquor, and bio-fuel businesses.

While India Glycols is already listed on the BSE and NSE, the management of IGL Spirits and Ennature Bio Pharma will apply to list their shares on the BSE and NSE, LiveMint Markets added. The outlet also noted that demergers often unlock value by letting investors view businesses separately, and by allowing each company to raise and deploy capital independently.

More like this

Sources

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.